Department of Laboratory, Kawashima Hospital, 1-39 Kitasakoichiban-cho, Tokushima, 770-0011, Japan.
Department of Kidney Disease, Kawashima Hospital, 1-39 Kitasakoichiban-cho, Tokushima, 770-0011, Japan.
CEN Case Rep. 2021 May;10(2):208-213. doi: 10.1007/s13730-020-00545-y. Epub 2020 Oct 20.
Successful kidney transplantation usually resolves secondary hyperparathyroidism (SHPT). However, some patients fail to normalize, and their condition is often referred to as tertiary hyperparathyroidism (THPT). Surgical consensus on the timing of post-transplant parathyroidectomy (PTX) for THPT has not been reached. Herein, we report a case of a 58-year-old post-transplant woman, considering the concrete timing of PTX for both SHPT and THPT. She initiated hemodialysis with end-stage renal disease at the age of 24, and underwent first kidney transplantation at the age of 28. When peritoneal dialysis (PD) was induced due to the worsening kidney function at the age of 50, the serum intact parathyroid hormone (iPTH) level remarkably increased (2332 pg/mL). Although cinacalcet was administered, the patient's iPTH levels were not sufficiently suppressed for seven years. Diagnostic images including ultrasound, computed tomography, and Tc-methoxyisobutylisonitrile scintigraphy indicated THPT as the reason for prolonged post-transplant hypercalcemia. Therefore, PTX was performed 14 months after the second transplantation. Histology showed nodular hyperplasia of all parathyroid glands, indicating autonomous secretion of parathyroid hormone. In general, patients with more severe THPT are recognized with more severe SHPT prior to transplantation during the dialysis period. We should consider a referral for surgery based on the individual risk factors. We recommend to perform parathyroidectomy earlier, before the kidney transplantation in the clinical suspicion of severe SHPT.
成功的肾移植通常可解决继发甲状旁腺功能亢进症(SHPT)。然而,有些患者无法恢复正常,其病情通常被称为三发性甲状旁腺功能亢进症(THPT)。对于 THPT 患者移植后甲状旁腺切除术(PTX)的时机,外科手术尚未达成共识。在此,我们报告了一例 58 岁女性患者的病例,该患者在移植后同时考虑了 SHPT 和 THPT 的具体 PTX 时机。她 24 岁时因终末期肾病开始接受血液透析,并于 28 岁时接受了首次肾移植。当 50 岁时因肾功能恶化而开始腹膜透析(PD)时,血清全段甲状旁腺激素(iPTH)水平显著升高(2332 pg/mL)。尽管给予了西那卡塞,但患者的 iPTH 水平在七年时间内均未得到充分抑制。包括超声、计算机断层扫描和 Tc-甲氧基异丁基异腈闪烁扫描在内的诊断图像表明,THPT 是导致移植后长期高钙血症的原因。因此,在第二次移植后 14 个月进行了 PTX。组织学显示所有甲状旁腺的结节性增生,提示甲状旁腺激素自主分泌。一般来说,在透析期间,在移植前患有更严重 THPT 的患者会在透析期间出现更严重的 SHPT。我们应根据个体危险因素考虑进行手术转诊。我们建议在临床怀疑严重 SHPT 时,在肾移植之前更早进行甲状旁腺切除术。